We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CWAN
201
DELISTED
Clearwater Analytics
CWAN
$1.35M 0.16%
53,537
+13,267
+33% +$298K
EXR icon
202
Extra Space Storage
EXR
$31.3B
$1.34M 0.16%
+7,457
New +$1.26M
DIN icon
203
Dine Brands
DIN
$448M
$1.34M 0.16%
42,996
+16,796
+64% +$541K
WIX icon
204
WIX.com
WIX
$2.36B
$1.34M 0.16%
7,987
-4,743
-37% -$763K
JHG
205
DELISTED
Janus Henderson
JHG
$1.33M 0.16%
+35,054
New +$1.27M
AM icon
206
Antero Midstream
AM
$10.4B
$1.33M 0.16%
88,592
+49,495
+127% +$721K
GFF icon
207
Griffon
GFF
$4.28B
$1.33M 0.16%
+18,996
New +$1.26M
BCPC
208
Balchem Corp
BCPC
$5.29B
$1.32M 0.16%
7,509
+2,276
+43% +$388K
LYFT icon
209
Lyft
LYFT
$5.73B
$1.3M 0.16%
101,851
+8,023
+9% +$95.8K
NTST
210
NETSTREIT Corp
NTST
$2.13B
$1.3M 0.16%
+78,426
New +$1.29M
FE icon
211
FirstEnergy
FE
$28.5B
$1.29M 0.15%
+29,131
New +$1.23M
HSY icon
212
Hershey
HSY
$36.6B
$1.29M 0.15%
+6,724
New +$1.31M
DESP
213
DELISTED
Despegar.com
DESP
$1.29M 0.15%
103,789
-8,725
-8% -$105K
RMBS icon
214
Rambus
RMBS
$10.4B
$1.28M 0.15%
30,408
-3,801
-11% -$184K
KLAC icon
215
KLA
KLAC
$266B
$1.28M 0.15%
16,560
-280
-2% -$22K
CHCT
216
Community Healthcare Trust
CHCT
$538M
$1.28M 0.15%
70,465
+47,949
+213% +$980K
OEC icon
217
Orion
OEC
$379M
$1.28M 0.15%
71,678
+51,750
+260% +$997K
CMP icon
218
Compass Minerals
CMP
$1.25B
$1.27M 0.15%
105,919
+90,774
+599% +$962K
ECL icon
219
Ecolab
ECL
$76.4B
$1.26M 0.15%
+4,950
New +$1.21M
AGRO icon
220
Adecoagro
AGRO
$1.48B
$1.26M 0.15%
113,844
+8,838
+8% +$92.5K
ARCO icon
221
Arcos Dorados Holdings
ARCO
$1.75B
$1.26M 0.15%
144,472
-52,858
-27% -$483K
GM icon
222
General Motors
GM
$78.7B
$1.25M 0.15%
27,890
-13,282
-32% -$616K
FN icon
223
Fabrinet
FN
$16.9B
$1.25M 0.15%
+5,285
New +$1.22M
TREE icon
224
LendingTree
TREE
$564M
$1.25M 0.15%
21,531
+313
+1% +$16.2K
RYAN icon
225
Ryan Specialty Holdings
RYAN
$5.59B
$1.24M 0.15%
18,684
-10,019
-35% -$626K
7 8
9
10 11

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.